The bright future of mRNA technology – InConversation Podcast #Episode1: w/Thomas D. Madden, Founder, Acuitas Therapeutics

Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer and BioNTech’s COVID-19 vaccine, the numerous applications of the company’s proprietary lipid nanoparticle (LNP) delivery technology, as well as the growth strategy of the Canadian company.

Related Interviews

Latest Report